Raymond James & Associates’s DNP Select Income Fund DNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.68M | Buy |
565,350
+26,351
| +5% | +$241K | ﹤0.01% | 1572 |
|
|
2024
Q2 | $4.43M | Buy |
538,999
+48,812
| +10% | +$423K | ﹤0.01% | 1664 |
|
|
2024
Q1 | $4.45M | Sell |
490,187
-2,858
| -0.6% | -$25.3K | ﹤0.01% | 1673 |
|
|
2023
Q4 | $4.18M | Sell |
493,045
-65,680
| -12% | -$593K | ﹤0.01% | 1652 |
|
|
2023
Q3 | $5.32M | Sell |
558,725
-28,381
| -5% | -$286K | ﹤0.01% | 1421 |
|
|
2023
Q2 | $6.15M | Sell |
587,106
-7,532
| -1% | -$78.7K | 0.01% | 1341 |
|
|
2023
Q1 | $6.55M | Buy |
594,638
+28,389
| +5% | +$323K | 0.01% | 1285 |
|
|
2022
Q4 | $6.37M | Buy |
566,249
+32,392
| +6% | +$354K | 0.01% | 1257 |
|
|
2022
Q3 | $5.53M | Buy |
533,857
+32,151
| +6% | +$358K | 0.01% | 1309 |
|
|
2022
Q2 | $5.44M | Buy |
501,706
+79,775
| +19% | +$899K | 0.01% | 1348 |
|
|
2022
Q1 | $4.99M | Buy |
421,931
+24,239
| +6% | +$272K | ﹤0.01% | 1513 |
|
|
2021
Q4 | $4.32M | Sell |
397,692
-1,384
| -0.3% | -$14.9K | ﹤0.01% | 1656 |
|
|
2021
Q3 | $4.25M | Buy |
399,076
+6,838
| +2% | +$73.3K | ﹤0.01% | 1596 |
|
|
2021
Q2 | $4.1M | Buy |
392,238
+114,787
| +41% | +$1.19M | ﹤0.01% | 1619 |
|
|
2021
Q1 | $2.74M | Buy |
277,451
+22,352
| +9% | +$228K | ﹤0.01% | 1807 |
|
|
2020
Q4 | $2.62M | Buy |
255,099
+16,332
| +7% | +$167K | ﹤0.01% | 1735 |
|
|
2020
Q3 | $2.4M | Buy |
238,767
+21,639
| +10% | +$230K | ﹤0.01% | 1635 |
|
|
2020
Q2 | $2.36M | Buy |
217,128
+2,629
| +1% | +$28.2K | ﹤0.01% | 1635 |
|
|
2020
Q1 | $2.1M | Buy |
214,499
+23,253
| +12% | +$279K | ﹤0.01% | 1537 |
|
|
2019
Q4 | $2.44M | Buy |
191,246
+18,190
| +11% | +$232K | ﹤0.01% | 1705 |
|
|
2019
Q3 | $2.23M | Buy |
173,056
+12,490
| +8% | +$155K | ﹤0.01% | 1711 |
|
|
2019
Q2 | $1.9M | Sell |
160,566
-143
| -0.1% | -$1.66K | ﹤0.01% | 1833 |
|
|
2019
Q1 | $1.85M | Buy |
160,709
+33,747
| +27% | +$378K | ﹤0.01% | 1810 |
|
|
2018
Q4 | $1.32M | Buy |
126,962
+21,287
| +20% | +$233K | ﹤0.01% | 1916 |
|
|
2018
Q3 | $1.17M | Buy |
105,675
+5,433
| +5% | +$59.8K | ﹤0.01% | 2143 |
|
|
2018
Q2 | $1.08M | Buy |
100,242
+14,411
| +17% | +$156K | ﹤0.01% | 2148 |
|
|
2018
Q1 | $882K | Sell |
85,831
-35,666
| -29% | -$369K | ﹤0.01% | 2224 |
|
|
2017
Q4 | $1.31M | Buy |
121,497
+421
| +0.3% | +$4.75K | ﹤0.01% | 1970 |
|
|
2017
Q3 | $1.39M | Buy |
121,076
+7,998
| +7% | +$90.3K | ﹤0.01% | 1888 |
|
|
2017
Q2 | $1.25M | Buy |
113,078
+12,354
| +12% | +$136K | ﹤0.01% | 1875 |
|
|
2017
Q1 | $1.09M | Buy |
100,724
+10,197
| +11% | +$108K | ﹤0.01% | 1925 |
|
|
2016
Q4 | $926K | Sell |
90,527
-16,742
| -16% | -$170K | ﹤0.01% | 1958 |
|
|
2016
Q3 | $1.1M | Buy |
107,269
+12,093
| +13% | +$128K | ﹤0.01% | 1828 |
|
|
2016
Q2 | $1.01M | Buy |
95,176
+35,696
| +60% | +$366K | ﹤0.01% | 1729 |
|
|
2016
Q1 | $595K | Buy |
59,480
+24,672
| +71% | +$235K | ﹤0.01% | 1956 |
|
|
2015
Q4 | $312K | Buy |
34,808
+1,860
| +6% | +$17.5K | ﹤0.01% | 2179 |
|
|
2015
Q3 | $296K | Sell |
32,948
-5,644
| -15% | -$55.9K | ﹤0.01% | 2140 |
|
|
2015
Q2 | $390K | Buy |
38,592
+5,861
| +18% | +$62.3K | ﹤0.01% | 2193 |
|
|
2015
Q1 | $344K | Buy |
32,731
+3,522
| +12% | +$37K | ﹤0.01% | 2169 |
|
|
2014
Q4 | $308K | Buy |
29,209
+728
| +3% | +$7.57K | ﹤0.01% | 2120 |
|
|
2014
Q3 | $288K | Buy |
28,481
+2,576
| +10% | +$26.4K | ﹤0.01% | 2050 |
|
|
2014
Q2 | $272K | Buy |
25,905
+3,214
| +14% | +$32.5K | ﹤0.01% | 2077 |
|
|
2014
Q1 | $222K | Sell |
22,691
-306,276
| -93% | -$2.95M | ﹤0.01% | 2049 |
|
|
2013
Q4 | $3.1M | Sell |
328,967
-9,964
| -3% | -$96K | 0.02% | 735 |
|
|
2013
Q3 | $3.26M | Sell |
338,931
-251,616
| -43% | -$2.49M | 0.03% | 650 |
|
|
2013
Q2 | $5.8M | Buy |
+590,547
| New | +$6.05M | 0.05% | 374 |
|
Other funds holding DNP
BCA
AWM
Raymond James & Associates's DNP Position: Q3 2024 in Review
Raymond James & Associates increased its DNP Select Income Fund (DNP) stake by 4.9% in Q3 2024, buying an estimated $241K and bringing the position to 565,350 shares worth $5.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1572.
Raymond James & Associates first reported a position in DNP in Q2 2013 and has held it in 46 quarters since. The position peaked at $6.55M in Q1 2023. 301 funds tracked by Wall St. Rank hold DNP as of Q3 2024.
- Raymond James & Associates held 565,350 shares of DNP Select Income Fund worth $5.68M as of Q3 2024.
- Raymond James & Associates bought 26,351 DNP Select Income Fund shares in Q3 2024, an estimated $241K.
- DNP Select Income Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1572 holding.
- Raymond James & Associates first reported a position in DNP Select Income Fund in Q2 2013 and has held it in 46 quarters since.
- Raymond James & Associates's DNP Select Income Fund position peaked at $6.55M in Q1 2023.
- 301 funds tracked by Wall St. Rank held DNP Select Income Fund as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.